Stanley Druckenmiller’s Duquesne Fund Maintains Heavy Natera Position Despite Recent Rally

Billionaire investor Stanley Druckenmiller continues to allocate roughly 17% of his $5.2 billion portfolio to diagnostic company Natera, raising questions about whether the stock remains attractive after an 80% surge.